Investment Trusts

Life Science REIT PLC

LABS:LSE

Life Science REIT PLC

Actions
  • Price (GBX)34.20
  • Today's Change-1.00 / -2.84%
  • Shares traded4.09m
  • 1 Year change-53.15%
  • Beta--
Data delayed at least 20 minutes, as of May 24 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Life Science REIT plc is a closed-ended real estate investment trust. The Company’s investment objective is to provide shareholders with an attractive level of total return. It seeks to invests in a diversified portfolio of properties across the United Kingdom, which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. It acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The Company retains flexibility to acquire individual buildings, a group of buildings across a single science park or the entirety of a science park. It also includes purchasing or developing buildings that are leased or intended to be leased to occupiers providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. Its investment adviser is Ironstone Asset Management Limited.

  • Revenue in GBP (TTM)19.94m
  • Net income in GBP-21.71m
  • Incorporated2021
  • Employees0.00
More ▼

Profile

Management group(s)Ironstone Asset Management Limited
AIC sectorProperty - UK Commercial
ISINGB00BP5X4Q29
Launch date19 Nov 2021
Share typeOrdinary Share
StructureInvestment Trust
Base currencyGBP

Objective

The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.

Managed by

Stephen Barrow, Simon Farnsworth, Pippa Stacey, Simon Hope, David Lewis, Matthew Barker, Ian Harris

Management & contract fees

The Investment Adviser will be paid an annual advisory fee of 1.1% of NAV up to GBP 500 m; 0.9% of NAV in excess of GBP 500m and up to GBP1b; and 0.75% of NAV in excess of GBP1B exclusive of VAT. The contract may be terminated on giving 24 months’ notice from the fourth anniversary of Admission.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
HSS Hire Group PLC349.11m4.24m69.97m2.12k17.170.3821.750.20040.00580.00580.48780.25980.810347.354.38164,364.400.98340.10351.320.136248.4551.321.210.13991.142.250.4366--4.911.58-79.31--6.87--
Doric Nimrod Air Three Ltd76.49m41.58m114.95m0.002.761.331.651.500.1890.1890.34770.39170.3593--1,912,344.00--19.53-1.4226.75-1.6699.1099.1354.35-6.85----0.00--6.240.95321,015.41-14.78--0.00
Life Science REIT PLC19.94m-21.71m119.70m0.00--0.4219--6.00-0.062-0.0620.0570.81070.0465--9.01---5.06---5.47--69.33---108.85----0.30370.2755--26.97--21.39------
Speedy Hire Plc434.30m-5.40m128.62m3.44k--0.79161.940.2962-0.0114-0.01140.93160.35180.881217.703.85128,681.50-1.102.70-1.473.6049.4654.71-1.243.330.96250.3030.494667.7113.913.39-94.39-38.9113.949.52
Amedeo Air Four Plus Ltd193.48m25.98m131.59m0.005.130.36840.85340.68010.08430.08430.59761.180.1295--33.96--1.74-1.251.93-1.34----13.43-10.23--1.810.7174--9.51-1.01137.65-23.77---17.87
Doric Nimrod Air Two Ltd125.02m66.88m152.39m0.000.91150.28431.291.221.351.352.534.340.4005--26.84--21.420.643628.750.7603----53.492.80----0.0246850.324.150.630920,934.85-9.87---22.16
Andrews Sykes Group plc78.75m17.76m254.29m479.0014.386.289.573.230.42250.42251.870.96670.90627.904.06164,398.8020.4417.4426.8021.9265.6961.6122.5520.541.89--0.2756110.04-5.130.04684.340.8218-10.681.71
Vp plc375.95m23.82m258.99m2.83k10.761.462.860.68890.59930.59939.474.430.793131.624.41--5.023.796.594.9724.4021.506.334.970.68724.780.535872.335.874.12-9.89-1.14-2.427.60
Data as of May 24 2024. Currency figures normalised to Life Science REIT PLC's reporting currency: UK Pound GBX

Institutional shareholders

66.54%Per cent of shares held by top holders
HolderShares% Held
Rathbones Investment Management Ltd.as of 07 May 202462.91m17.98%
Investec Wealth & Investment Ltd.as of 23 Nov 202361.38m17.54%
Schroder & Co. Ltd.as of 31 Dec 202229.74m8.50%
Sarasin & Partners LLPas of 01 Sep 202317.45m4.99%
Cerno Capital Partners LLPas of 31 Dec 202217.29m4.94%
Legal & General Investment Management Ltd.as of 19 Jul 202310.91m3.12%
Momentum Global Investment Management Ltd.as of 30 Apr 20249.23m2.64%
Baillie Gifford & Co.as of 30 Apr 20249.15m2.62%
Hawksmoor Investment Management Ltd.as of 30 Apr 20238.07m2.31%
BlackRock Investment Management LLCas of 30 Apr 20246.76m1.93%
More ▼
Data from 30 Apr 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.